Related Experiment Video
Updated: May 2, 2026
Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
Published on: January 29, 2019
Emerging opportunities for the combination of molecularly targeted drugs with radiotherapy
E J Searle1, T M Illidge2, I J Stratford3
1Manchester Pharmacy School, University of Manchester, Manchester, UK; Targeted Therapy Group, Institute of Cancer Sciences, University of Manchester, Manchester, UK.
Abstract:
Recent drug discovery developments in the field of small molecule targeted agents have led to much interest in combining these with radiotherapy. There are good preclinical data to suggest this approach worthy of investigation and in this review we discuss how this has translated into recent clinical trials. The outcome of clinical trials investigating radiotherapy/targeted drug combinations published in the last 5 years is discussed, as are trials in progress. The perceived future opportunities and challenges in the development of this exciting area are considered.
Insights
Combining small molecule targeted agents with radiotherapy shows promise. Recent clinical trials and ongoing studies are evaluating this approach, with preclinical data supporting its potential in cancer treatment.
Area of Science:
- Oncology
- Radiotherapy
- Pharmacology
Background:
- Small molecule targeted agents represent a significant advancement in cancer therapy.
- Preclinical data suggest synergistic effects when combining targeted agents with radiotherapy.
- Translational research is crucial for advancing novel cancer treatment strategies.
Purpose of the Study:
- To review recent clinical trials combining radiotherapy with small molecule targeted agents.
- To discuss the outcomes of published trials and ongoing investigations.
- To explore future opportunities and challenges in this therapeutic area.
Main Methods:
- Systematic review of clinical trials published within the last five years.
- Analysis of trial outcomes for radiotherapy/targeted drug combinations.
- Discussion of ongoing clinical trials and future research directions.
Main Results:
- Clinical trials investigating radiotherapy and targeted drug combinations have yielded varied outcomes.
- Several trials are currently in progress, evaluating different drug/radiotherapy combinations.
- The review synthesizes findings from recent studies to inform future development.
Conclusions:
- The combination of small molecule targeted agents and radiotherapy is a promising area of cancer research.
- Clinical translation of preclinical findings is ongoing, with several trials underway.
- Further research is needed to optimize treatment protocols and overcome challenges in this field.
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:57Targeted Cancer Therapies
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:50Combination Therapies and Personalized Medicine
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:27Tumor Immunotherapy